Coherus Biosciences | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
AbbVie USD 5.52B 1.73B 2024-12
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
ALKERMES USD 399.81M 108.66M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amarin USD 119.52M 1.51M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Baxter International USD 1.76B 344M 2024-12
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Fujifilm JPY 172.11B 44.14B 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
Ironwood Pharmaceuticals USD 88.56M 348K 2024-12
Merck USD 8.63B 4.61B 2025-03
Myriad Genetics USD 91.8M 10.6M 2025-03
Pacira USD 283.61M 6.84M 2025-03
Perrigo USD 409.9M 148.9M 2025-03
Pfizer USD 1.43B 387M 2025-03
PTC Therapeutics USD 2.03B 1.25B 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Teva Pharmaceutical Industries USD 1.7B 1.6B 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Xencor USD 39.67M 1.2M 2025-03
Zoetis USD 1.72B 264M 2025-03



Coherus Biosciences Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.